Malik RA, Aldinc E, Chan SP, et al
Injectable GHK-Cu aims to restore youthful systemic signaling something topical GHK-Cu formulations can do, but not at the therapeutic concentrations achieved via injection
At BioPrime Medical, we tailor our BPC-157 therapy to meet your specific health needs and goals

Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback
Retail Price: $27.25 $19.49 You Save: $7.76 Neo-Predef with Tetrac
One human study found that 7 of 12 people with chronic knee pain experienced relief for over six months after receiving a single BPC-157 knee injection